Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.
about
Association of apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer's disease brainIn vitro enhancement of dendritic cell-mediated anti-glioma immune response by graphene oxideHigh mobility group box2 promoter-controlled suicide gene expression enables targeted glioblastoma treatmentCaspase-3 and survivin expression in primary atypical and malignant meningiomasMinocycline is cytoprotective in human trabecular meshwork cells and optic nerve head astrocytes by increasing expression of XIAP, survivin, and Bcl-2.Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours--A prognostic test after surgical resection.Epigallocatechin-3-gallate enhances the therapeutic effects of leptomycin B on human lung cancer a549 cells.Effects of JC virus infection on anti-apoptotic protein survivin in progressive multifocal leukoencephalopathy.Epigenetic Role of Histone 3 Lysine Methyltransferase and Demethylase in Regulating Apoptosis Predicting the Recurrence of Atypical MeningiomaMolecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 5: apoptosis and cell cycle.Expression of survivin protein in human colorectal carcinogenesis.Tetraploidy/aneuploidy and stem cells in cancer promotion: The role of chromosome passenger proteins.Fermented mistletoe extract as a multimodal antitumoral agent in gliomas.Cellular pathology in multiple system atrophy.Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma.Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome.Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects.Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral gliomaIdentification of gene markers associated with aggressive meningioma by filtering across multiple sets of gene expression arrays.The Lewy body in Parkinson's disease and related neurodegenerative disorders.Challenges in the development of a survivin vaccine (SurVaxM) for malignant glioma.Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade.Role of Apolipoproteins and α-Synuclein in Parkinson's Disease.The chaperone protein clusterin may serve as a cerebrospinal fluid biomarker for chronic spinal cord disorders in the dog.Survivin small interfering RNA suppresses glioblastoma growth by inducing cellular apoptosis.Differential gene expression and alternative splicing of survivin following mouse sciatic nerve injury.Correlation of survivin and B-cell lymphoma 2 expression with pathological malignancy and anti-apoptotic properties of glial cell tumors.Structural characterization of clusterin-chaperone client protein complexes.Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxia-induced up-regulation.A polymorphism in the promoter region of the survivin gene is related to hemorrhagic transformation in patients with acute ischemic stroke.Survivin expression in medulloblastoma: a possible marker for survival.Apoptosis and proliferation markers in diffusely infiltrating astrocytomas: profiling of 17 molecules.Signals of apoptotic pathways in several types of meningioma.Lack of prognostic significance of survivin in pediatric medulloblastoma.Survivin is a negative prognostic marker in medulloblastoma.
P2860
Q24302165-55880C0F-5419-4165-8A5B-69D003155E3DQ28389458-8F87D345-2A89-44BA-9EB6-8C06EFEC426EQ33713725-F4BC80BC-5A9C-4634-A407-9C929A985842Q33771661-269DCCA0-49C1-4584-994E-101B49A6DF3FQ34019667-083327E0-A1AA-4505-A249-EF165A85C7A7Q34467060-67B049E5-227A-4E5F-97AD-049A48836550Q35422300-8C188142-593A-43B3-8080-E560A2D8C63DQ35691615-3507B9D3-9BDB-421B-B0B6-1585508A821CQ35905146-92817EAC-EC1A-4FE9-A7A2-F360D5535F8FQ36118431-114B9221-A310-4DF4-AE9C-52B5F1D83297Q36178566-A449A69F-AAA8-4B47-AD7A-9200AE3F2FEAQ36332561-5790E101-ADE8-41D7-B98B-E45E14F75E24Q36361068-25717A08-3479-4A3A-A8A5-4446E977F904Q36589164-B1D11E0A-4426-4991-80D8-C2DF7EDB11F8Q36613456-056B5AF7-ADEC-4188-9DFD-01814554EA52Q36616158-21BCD624-97D2-45C9-B3CB-1178AF30664FQ36925296-E3481A1A-534F-4EDD-9E27-7C1FB24BFC85Q36948849-A4F69C2B-8FDA-408F-B068-DDAB269607DEQ37341271-77676C0C-61C9-4E8A-ADF2-FAD2348ABAB3Q38012653-B90A9BE2-88BB-416C-BEA4-B4CC6E4080E3Q38187480-35814CF1-FED4-43AA-9E29-FA83E7B87CCAQ38603178-21352575-6A9A-4826-9C54-94DD799C9D05Q38659590-B77BC332-C2E0-44AD-8C12-65A81151CB5EQ38687512-BF067A4A-71CB-4ED1-9782-B63EDBD7642DQ39360938-3FDDA3A4-57D2-45E3-879C-E52775C08BFDQ39991014-F6DC6C09-353D-48C5-B450-EE637BC5189DQ41869508-097ED614-99E7-49EC-ACF0-5424589EA09FQ42575332-0AEB9277-F38D-4B18-B585-3ABEDC41F2B7Q42792283-D038C2CF-ABFA-4E80-B7F1-FD1F9C139926Q44493252-FF8B6DCD-2ACF-4DDB-81DE-9949B3A4FF4EQ45963400-C935481E-687E-4840-94ED-15BFBCFA889EQ48427363-C671150E-E75F-4CEC-B68F-8C3343006567Q50071533-AD0B7F35-5921-4136-A333-E8A330BB4167Q55463001-E7CFDA76-0B7C-486C-A281-9B75012969BDQ55471231-4758C0F6-C8A9-4E86-BF5F-6E9DF6B20EA5
P2860
Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Expression of survivin, an inh ...... tumors of the nervous system.
@ast
Expression of survivin, an inh ...... tumors of the nervous system.
@en
type
label
Expression of survivin, an inh ...... tumors of the nervous system.
@ast
Expression of survivin, an inh ...... tumors of the nervous system.
@en
prefLabel
Expression of survivin, an inh ...... tumors of the nervous system.
@ast
Expression of survivin, an inh ...... tumors of the nervous system.
@en
P2093
P1476
Expression of survivin, an inh ...... tumors of the nervous system.
@en
P2093
Gerald R Hankins
Gregory A Helm
M Beatriz S Lopes
Tsutomu Sasaki
P2888
P304
P356
10.1007/S00401-002-0532-X
P577
2002-03-29T00:00:00Z
P6179
1030622938